CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Quantitative Analysis of Hepatic CCCDNA during Combination Therapy of Peginterferon ALFA 2B Plus Adefovir Dipivoxil in Patients with Chronic Hepatitis B: Interim Analysis of a single Center Pilot Study
DOI 10.1055/s-2004-831755
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Wursthorn, P Buggisch, F Metzler, B Zöllner, M Zankel, C Fischer, S Xiong, C Gibbs, H Greten, J Petersen
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Hepatitis B Virus cccDNA is the replicative intermediate in the nuclei of infected hepatocytes that is responsible for viral persistence during chronic HBV infection and antiviral therapy. The aims of this study were 1) to determine changes in intrahepatic cccDNA levels in paired biopsy samples from patients during therapy with Peginterferon alfa 2b and adefovir dipivoxil (primary endpoint) using a quant…
Zitieren
Zitierempfehlung
K Wursthorn, P Buggisch, F Metzler, B Zöllner, M Zankel, C Fischer, S Xiong, C Gibbs, H Greten, J Petersen (2004) Quantitative Analysis of Hepatic CCCDNA during Combination Therapy of Peginterferon ALFA 2B Plus Adefovir Dipivoxil in Patients with Chronic Hepatitis B: Interim Analysis of a single Center Pilot Study. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-2004-831755
Mit CareLit weiterarbeiten